# The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer

> **NCT00261456** · — · ACTIVE_NOT_RECRUITING · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 3500 (actual)

## Conditions studied

- Prostate Cancer
- BRCA Mutation
- Mismatch Repair Gene Mutation
- Genetic Predisposition to Disease

## Interventions

- **DIAGNOSTIC_TEST:** PSA test
- **PROCEDURE:** Prostate Biopsy

## Key facts

- **NCT ID:** NCT00261456
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2005-03
- **Primary completion:** 2030-02-28
- **Final completion:** 2030-03
- **Target enrollment:** 3500 (ACTUAL)
- **Last updated:** 2025-09-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261456, "The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00261456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*